Skip to main content
. 2021 Jan 19;13(1):124. doi: 10.3390/pharmaceutics13010124

Figure 7.

Figure 7

Bioactives that inhibit the six most affected targets (COX2, CYP1A2, CYP3A4, CYP2C9, BCRP, and P-gP). Location of the targets is indicative, since they are expressed in several other tissues.